Targeted therapy of metastatic renal cell cancer
10.3760/cma.j.issn.1673-422X.2014.09.010
- VernacularTitle:转移性肾细胞癌的靶向治疗
- Author:
Hongbiao WANG
;
Xuyuan LI
;
Wenzhao LIN
- Publication Type:Journal Article
- Keywords:
Kidney neoplasms;
Molecular targeted therapy;
Vascular endothelial growth factor A
- From:
Journal of International Oncology
2014;(9):672-674
- CountryChina
- Language:Chinese
-
Abstract:
Targeted therapy of anti-angiogensis strategy is the standard treatment for metastatic renal cell cancer.In recent years,a number of new generation of anti-angiogensis agents have been tested in clinical trials,some of which have achieved promising outcomes.Other pathway inhibitors such as inhibitors of mamma-lian target of rapamycin and fibroblast growth factor receptor pathway have made progresses in some extent.
